Formation of a multidisciplinary team as a guarantee of success in preserving fertility in cancer patients

Background. The field of medicine that studies the possibility of preserving reproductive function in cancer patients is intensively developing in the world. Many countries are studying this issue by creating their own databases and national guidelines. In Russia, despite the interest in this problem and discussions at many national conferences, there are no national programs, protocols and clinical recommendations. It creates an obstacle to receiving this type of care for cancer patients. In this regard, the creation of an interdisciplinary system on the preservation of reproductive function in cancer patients becomes relevant. Aim. Formation of interdisciplinary relations between oncologists / hematologists, obstetricians-gynecologists and fertility doctors in order to improve the effectiveness of the care provided on fertility preservation in cancer patients.

Materials and methods. The study involved oncologists from the S. S. Yudin City Clinical Hospital, Moscow Healthcare Department, obstetricians-gynecologists and hematologists from the City Clinical Hospital No. 52, Moscow Healthcare Department, as well as reproductive health specialists from the Institute of Reproductive Medicine REMEDI. Oncological patients were recruited on the basis of the S. S. Yudin City Clinical Hospital. A standard scope of examination was undertaken and they were offered antitumor treatment within the framework of the tumor board, taking into account the stage of the disease and the morphological type of the tumor. An obstetrician-gynecologist received patients on the basis of the City Clinical Hospital No. 52. An individual card specially designed for this study was filled in for each patient. The card included data on anamnesis, examination and additional examination methods. A reproductive health specialist received patients on the basis of the Institute of Reproductive Medicine REMEDI. The information obtained during the consultations was added into the specially designed cancer fertility register, with a subsequent assessment of each patient’s status. Results. A multidisciplinary team on fertility preservation was formed with a clear routing of cancer patients when referring to appropriate specialists. Since 2023, 42 oncological and hematological patients have been consulted. A unified database on oncofertility was set up.

Conclusion. Our study confirms the need to create a multidisciplinary team to address the issues of preserving reproductive function in cancer patients, providing adequate information to patients about the risks of developing premature ovarian failure during treatment, about possible options for preserving fertility, improving the quality of life and the likelihood of childbirth after the completion of antitumor treatment.

1. Lambertin M., Mastro L.D., Pescio M.C. et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med 2016;14(1). DOI: 10.1186/s12916-015-0545-7

2. Bewtra C., Acharya N. Preservation of fertility in cancer patients: A narrative review. Cureus 2023;15(10):e47910. DOI: 10.7759/cureus.47910

3. McClam M., Xiao S. Preserving oocytes in oncofertility. Biol Reprod 2022;106(2):328–37. DOI: 10.1093/biolre/ioac008.

4. Lavrinovich O.E., Karitskiy A.P., Kotiv Kh.B. Relevance and legal basis for preserving fertility of cancer patients: Institutional experience and literature review. Voprosy onkologii = Oncology Issues 2024;70(2):368–76. (In Russ.). DOI: 10.37469/0507-3758-2024-70-2-368-376

5. Linkeviciute A., Boniolo G., Chiavari L. et al. Fertility preservation in cancer patients: The global framework. Cancer Treat Rev 2014;40(8):1019–27. DOI: 10.1016/j.ctrv.2014.06.001

6. Gatta G., Botta L., Rossi S. et al. Childhood cancer survival in Europe 1999–2007: Results of EUROCARE-5 – a population based study. Lancet Oncol 2014;15(1):35–47. DOI: 10.1016/S1470-2045(13)70548-5

7. Armenian S.H., Landier W., Hudson M.M. et al. Children’s Oncology Group’s 2013 blueprint for research: Survivorship and outcomes. Pediatr Blood Cancer 2013;60(6):1063–8. DOI: 10.1002/pbc.24422

8. Lambertin M., Peccatori F.A., Demeestere I. et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelinesy. Ann Oncol 2020;31(12):1664–78. DOI: 10.1016/j.annonc.2020.09.006

9. Kutluk O., Brittany E., Partridge A.H. et al. Fertility preservation in patients with cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol 2018;36(19):1994–2001. DOI: 10.1200/JCO.2018.78.1914 10. Laurie H., Berek J. S., Diaz I. et al. FIGO statement: Fertility preservation. Int J Gynecol Obstet 2023;163(3):790–4. DOI: 10.1002/ijgo.15187

10. Nazarenko T.A., Ashrafyan L.A., Dzhanashvili L.G. et al. Retention of reproductive material in cancer patients as a sociomedical and organizational problem. P.A. Herzen Journal of Oncology = Onkologiya. Zhurnal im. P.A. Gertsena 2020;9(1):60–5. (In Russ.). DOI: 10.17116/onkolog2020901160

11. Chernus N.Yu., Babayants E.V., Voytsitskiy V.E. et al. The legal aspects of fertility in a practical gynecological oncology. Opukholi zhenskoy reproduktivnoy systemy = Tumors of Female Reproductive System 2018;14(1):91–5. (In Russ.).

12. Rashedi A.S., de Roo S.F., Ataman L.M. et al. Survey of fertility preservation options available to patients with cancer around the globe. J Glob Oncol 2018;2(6):331–4. DOI: 10.1200/JGO.2016.008144